Adjuvant anti-VEGF therapy for overall survival and relapse-free survival in patients with resected non-metastatic colorectal cancer

David Lok Hang Chan; David Espinoza; Joseph Chan; Adrian Lee; Wasek Faisal; Eva Segelov; Nick Pavlakis

doi:10.1002/14651858.CD012460

Adjuvant anti-VEGF therapy for overall survival and relapse-free survival in patients with resected non-metastatic colorectal cancer

David Lok Hang Chan, David Espinoza, Joseph Chan, Adrian Lee, Wasek Faisal, Eva Segelov, Nick Pavlakis

Research output: Contribution to journal › Article › Research › peer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of the use of anti-angiogenic agents (VEGF inhibitors) in the adjuvant setting after resection in patients diagnosed with resectable colorectal cancer. This would permit a summary of the safety and effectiveness of anti-VEGF therapies overall, as well as in pre-planned prognostic subgroups, and identify areas where further research could be directed.

Original language	English
Article number	CD012460
Number of pages	16
Journal	Cochrane Database of Systematic Reviews
Volume	2016
Issue number	12
DOIs	https://doi.org/10.1002/14651858.CD012460
Publication status	Published - 7 Dec 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/14651858.CD012460

24934501-oaFinal published version, 204 KB

Cite this

@article{d4dfdd95960d403c8c009773be3fe4f8,

title = "Adjuvant anti-VEGF therapy for overall survival and relapse-free survival in patients with resected non-metastatic colorectal cancer",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of the use of anti-angiogenic agents (VEGF inhibitors) in the adjuvant setting after resection in patients diagnosed with resectable colorectal cancer. This would permit a summary of the safety and effectiveness of anti-VEGF therapies overall, as well as in pre-planned prognostic subgroups, and identify areas where further research could be directed.",

author = "Chan, \{David Lok Hang\} and David Espinoza and Joseph Chan and Adrian Lee and Wasek Faisal and Eva Segelov and Nick Pavlakis",

year = "2016",

month = dec,

day = "7",

doi = "10.1002/14651858.CD012460",

language = "English",

volume = "2016",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley \& Sons",

number = "12",

}

TY - JOUR

T1 - Adjuvant anti-VEGF therapy for overall survival and relapse-free survival in patients with resected non-metastatic colorectal cancer

AU - Chan, David Lok Hang

AU - Espinoza, David

AU - Chan, Joseph

AU - Lee, Adrian

AU - Faisal, Wasek

AU - Segelov, Eva

AU - Pavlakis, Nick

PY - 2016/12/7

Y1 - 2016/12/7

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of the use of anti-angiogenic agents (VEGF inhibitors) in the adjuvant setting after resection in patients diagnosed with resectable colorectal cancer. This would permit a summary of the safety and effectiveness of anti-VEGF therapies overall, as well as in pre-planned prognostic subgroups, and identify areas where further research could be directed.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of the use of anti-angiogenic agents (VEGF inhibitors) in the adjuvant setting after resection in patients diagnosed with resectable colorectal cancer. This would permit a summary of the safety and effectiveness of anti-VEGF therapies overall, as well as in pre-planned prognostic subgroups, and identify areas where further research could be directed.

UR - https://www.scopus.com/pages/publications/85003601586

U2 - 10.1002/14651858.CD012460

DO - 10.1002/14651858.CD012460

M3 - Article

AN - SCOPUS:85003601586

SN - 1469-493X

VL - 2016

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 12

M1 - CD012460

ER -

Adjuvant anti-VEGF therapy for overall survival and relapse-free survival in patients with resected non-metastatic colorectal cancer

Abstract

UN SDGs

Access to Document

Other files and links

Cite this